Weinstein Steven F
Department of Pediatrics, Division of Allergy and Clinical Immunology, College of Medicine, University of California at Irvine, Irvine, California, USA.
Allergy Asthma Proc. 2002 Jan-Feb;23(1):1-3.
Allergic rhinitis is a common allergic condition. There are a variety of pharmacologic treatments, including antihistamines, oral decongestants, and intranasal corticosteroids. Leukotrienes cause significant nasal obstruction. Leukotriene receptor antagonists decrease symptoms and improve quality of life in patients with seasonal allergic rhinitis. Similar to antihistamines, antileukotrienes appear to be less efficacious than nasal corticosteroids. Combination therapy of histamine and leukotriene antagonists produces symptomatic improvement as well as improved quality of life. Areas of study for combination antimediator therapy include expanding the initial findings with regard to nasal steroids, investigation of patient preference and compliance, use in perennial allergic rhinitis, and treatment of "one airway," i.e., treatment of concurrent allergic rhinitis and asthma.
过敏性鼻炎是一种常见的过敏病症。有多种药物治疗方法,包括抗组胺药、口服减充血剂和鼻用皮质类固醇。白三烯会导致严重的鼻塞。白三烯受体拮抗剂可减轻季节性过敏性鼻炎患者的症状并改善生活质量。与抗组胺药类似,抗白三烯药物的疗效似乎不如鼻用皮质类固醇。组胺和白三烯拮抗剂联合治疗可改善症状并提高生活质量。联合抗介质治疗的研究领域包括扩大关于鼻用类固醇的初步研究结果、调查患者偏好和依从性、用于常年性过敏性鼻炎以及治疗“同一气道”,即同时治疗过敏性鼻炎和哮喘。